![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, December 20, 2019 11:44:16 AM
My understanding is that there is a new process in Australia that can accelerate the approval of promising drugs after a successful Phase 2 study whereby you can begin selling the drug and continue collecting data into a phase 4 to achieve final approval.
Since DMAC increased the stroke study to 100 patients which is supposed to report topline phase 2 results data in 1Q/20, I'm wondering if they are applying for this "provisional approval?"
Any information or thoughts about this possibility would be appreciated.
Recent DMAC News
- DiaMedica Therapeutics Announces Closing of $11.8 Million Private Placement • Business Wire • 07/01/2024 12:00:00 PM
- DiaMedica Therapeutics Announces $11.8 Million Private Placement • Business Wire • 06/26/2024 12:15:00 PM
- DiaMedica Therapeutics Announces Expansion of DM199 (Rinvecalinase Alfa) Program Into Preeclampsia • Business Wire • 06/26/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 09:06:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 08:59:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 08:58:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 08:41:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 08:35:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 08:29:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 08:21:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 08:14:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 08:02:39 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/24/2024 08:01:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 08:00:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 08:34:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:30:55 PM
- DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2024 Financial Results • Business Wire • 05/08/2024 08:30:00 PM
- DiaMedica Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update May 9, 2024 • Business Wire • 05/02/2024 12:55:00 PM
- DiaMedica Therapeutics Announces First Patient Dosed in Relaunch of its Pivotal Phase 2/3 ReMEDy2 Trial of DM199 for the Treatment of Acute Ischemic Stroke • Business Wire • 04/17/2024 08:08:00 PM
- DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2023 Financial Results • Business Wire • 03/19/2024 08:15:00 PM
- DiaMedica Therapeutics Announces Poster Presentation at International Stroke Conference • Business Wire • 01/29/2024 09:13:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 09:23:11 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 09:12:31 PM
- DiaMedica Therapeutics Appoints Dr. Lorianne Masuoka as Chief Medical Officer • Business Wire • 01/22/2024 01:23:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 10:05:18 PM
FEATURED BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • Jul 2, 2024 7:19 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM